FDA recall, , Low risk
American Red Cross Apheresis Platelets
Apheresis Platelets, PAS, Leukocytes Reduced, Pathogen Reduced were distributed without platelet yield testing.
Recall ended Aug 5, 2026. Still check yours.
Summary by Recall Canary from the FDA notice
What happened
The American National Red Cross began a recall of Apheresis Platelets, PAS, Leukocytes Reduced, Pathogen Reduced on March 17, 2026, because platelet yield testing was not performed before the product was distributed. The recall was added to the FDA's Enforcement Report and classified by the FDA on August 5, 2026, and in the FDA's weekly enforcement report on August 12, 2026. The product was distributed in Minnesota, Missouri and Wisconsin.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:
- Check the FDA or company notice for instructions specific to this product.
- Ask your pharmacist or doctor whether your lot is affected and what to do.
Is yours affected?
Compare these details with yours, then check the recall notice to see which units are recalled.
Apheresis Platelets, PAS, Leukocytes Reduced, Pathogen Reduced
- Affected units
- W18172689696400E (triple collection); W18172689694400M (triple collection); W18172689695600E
Recall details
- Company began the recall
- Company
- The American National Red Cross
- Hazard
- Quality testing problem
- Risk
Low risk
Taking it is unlikely to cause health problems.
FDA Class III recall · How risk is rated
- Event ID
- 99396
- Recall number
- B-0169-2026
All recalls from The American National Red Cross
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report · Classified by FDA · Recall ended
Listed on Recall Canary
In FDA's weekly enforcement report
Summary updated
